Masao Harada
Sapporo, 0030804, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Efficacy and feasibility of percutaneous needle biopsy in molecular profiling of thoracic cancers via next-generation sequencing.
Journal: Respiratory investigation
Published: April 28, 2025
Phase II study of S-1 and irinotecan combination therapy in EGFR-mutated non-small cell lung cancer resistant to epidermal growth factor receptor tyrosine kinase inhibitor: North Japan Lung Cancer Study Group Trial 0804 (NJLCG0804).
Journal: Medical oncology (Northwood, London, England)
Published: March 28, 2022
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 29, 2020
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival.
Journal: Heliyon
Published: December 14, 2019
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).
Journal: Cancer chemotherapy and pharmacology
Published: October 19, 2019
A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 30, 2019
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
Journal: The oncologist
Published: October 10, 2018
A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).
Journal: International journal of clinical oncology
Published: February 09, 2018
Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
Journal: Clinical lung cancer
Published: January 29, 2018
The Effectiveness of Afatinib in a Patient with Advanced Lung Adenocarcinoma Harboring Rare G719X and S768I Mutations.
Journal: Internal medicine (Tokyo, Japan)
Published: December 12, 2017
Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13).
Journal: Oncology letters
Published: November 20, 2017
Last Updated: 09/26/2026